Cytoreductive Surgery and HIPEC: Patient Selection and Outcomes for Metastatic Colon Cancer

被引：0
作者：
TSeng, J. [1 ]
Alban, R. F. [1 ]
Gangi, A. [1 ]
Amersi, F. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P157
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Is hyperthermic intraperitoneal Chemoperfusion (HIPEC) dispensable after cytoreductive Surgery in Patients with peritoneal metastatic Colorectal Cancer?
    Anthuber, M.
    Strassmuller, A.
    CHIRURG, 2021, 92 (06): : 573 - 573
  • [22] Surgical Management of Metastatic Colorectal Cancer: A Single-Centre Experience on Oncological Outcomes of Pulmonary Resection vs Cytoreductive Surgery and HIPEC
    Wong E.Y.T.
    Tan G.H.C.
    Ng D.W.J.
    Koh T.P.T.
    Kumar M.
    Teo M.C.C.
    Journal of Gastrointestinal Cancer, 2017, 48 (4) : 353 - 360
  • [23] CYTOREDUCTIVE SURGERY AND HIPEC FOR THE TREATMENT OF ENDOMETRIAL CANCER WITH PERITONEAL CARCINOMATOSIS
    Halkia, E.
    Kourakos, A.
    Metaxas, T.
    Kotsopoulos, P.
    Vaikos, D.
    Kalakonas, A.
    Papadopoulos, A.
    Christakis, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1071 - 1071
  • [24] Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study
    Simkens, Geert A.
    van Oudheusden, Thijs R.
    Braam, Hidde J.
    Wiezer, Marinus J.
    Nienhuijs, Simon W.
    Rutten, Harm J.
    van Ramshorst, Bert
    de Hingh, Ignace H.
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 113 (05) : 548 - 553
  • [25] RECURRENT OVARIAN CANCER TREATED BY SECONDARY CYTOREDUCTIVE SURGERY AND HIPEC
    Panoskaltsis, T.
    Tzavara, C.
    Pallas, N.
    Karamveri, C.
    Kiziridis, D.
    Hristakis, C.
    Kyriakopoulos, V.
    Kalakonas, A.
    Vaikos, D.
    Tentes, A-A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A505 - A506
  • [26] Cytoreductive surgery for metastatic colorectal cancer
    Khomiakov, V
    Vashakmadze, L
    Sidorov, D
    Trachtenberg, A
    Pikin, O
    ANNALS OF ONCOLOGY, 2006, 17
  • [27] Is cytoreductive surgery with HIPEC adequately funded?
    Yurttas, Can
    Kalmbach, Sarah
    Ansorge, Emilia
    Bezmawi, Mohamed
    Blumenstock, Gunnar
    Loeffler, Markus W.
    Mihaljevic, Andre L.
    Ernst, Christian
    Holderried, Martin
    CHIRURGIE, 2025,
  • [28] A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC
    Lee, Rachel M.
    Gamboa, Adriana C.
    Turgeon, Michael K.
    Zaidi, Mohammad Y.
    Kimbrough, Charles
    Leiting, Jennifer
    Grotz, Travis
    Lee, Andrew J.
    Fournier, Keith
    Powers, Benjamin
    Dineen, Sean
    Baumgartner, Joel M.
    Veerapong, Jula
    Mogal, Harveshp
    Clarke, Callisia
    Wilson, Gregory
    Patel, Sameer
    Hendrix, Ryan
    Lambert, Laura
    Pokrzywa, Courtney
    Abbott, Daniel E.
    LaRocca, Christopher J.
    Raoof, Mustafa
    Greer, Jonathan
    Johnston, Fabian M.
    Staley, Charles A.
    Cloyd, Jordan M.
    Maithel, Shishir K.
    Russell, Maria C.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (01) : 187 - 195
  • [29] Optimizing patient selection for secondary cytoreductive surgery in recurrent endometrial cancer
    Vargiu, Virginia
    Rosati, Andrea
    Tortorella, Lucia
    Giannarelli, Diana
    Capozzi, Vito Andrea
    Gallotta, Valerio
    Gioe, Alessandro
    Di Stefano, Ettore
    Corrado, Martina
    Berretta, Roberto
    Cosentino, Francesco
    Scambia, Giovanni
    Fanfani, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [30] Cytoreductive Surgery and Hipec: A National Experience
    McInerney, N.
    Keyes, A.
    Kelly, M.
    Khan, M. F.
    Bolger, J. C.
    McCormack, O.
    Brennan, D.
    Cahill, R.
    Shields, C.
    Mulsow, J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 5) : S112 - S112
12345